What is the main purpose of this 8-K filing?

The primary purpose of this 8-K filing is to report on the completion of HCA Healthcare's issuance and sale of $500 million in 6.25% Notes due February 15, 2013, and to file the relevant underwriting agreements and note indentures as exhibits.

What does the issuance of $500 million in notes mean for HCA's financial position?

The issuance of $500 million in notes increases HCA's total debt and financial leverage. It also establishes a new interest expense of 6.25% on this principal amount, which will impact the company's profitability and cash flow from operations.

Are there any financial results or operational updates in this filing?

No, this 8-K filing is specifically related to a debt issuance event. It does not contain any financial results, operational performance updates, or other material business developments beyond the debt transaction itself.

What are the key documents filed as exhibits?

The key documents filed as exhibits are the Underwriting Agreement (Terms) dated February 5, 2003, and the separate indentures for the $400,000,000 and $100,000,000 principal amounts of the 6.25% Notes due February 15, 2013.

HCA 8-K SEC Disclosure — Feb 12, 2003

Summary

HCA Healthcare, Inc. (HCA) filed a Current Report on Form 8-K on February 11, 2003, to report on the issuance and sale of $500 million in aggregate principal amount of 6.25% Notes due February 15, 2013. This filing primarily serves to incorporate by reference and file new exhibits related to this significant debt offering. Investors should note that this report is focused on the debt issuance rather than operational performance or financial results. The primary event is the completion of the sale of these notes, which will impact the company's leverage and interest expense. The filing includes the underwriting agreement and the specific note indentures as exhibits.

Key Highlights

1HCA Healthcare completed the issuance and sale of $500 million in aggregate principal amount of 6.25% Notes.
2The notes mature on February 15, 2013, indicating a 10-year debt maturity at the time of issuance.
3This 8-K filing is primarily an informational filing related to the debt offering, providing supporting documentation.
4Key exhibits filed include the Underwriting Agreement (Terms) dated February 5, 2003, and the specific indentures for the $400 million and $100 million notes.
5The debt issuance suggests HCA is raising capital, potentially for general corporate purposes, acquisitions, or refinancing existing debt.
6The coupon rate of 6.25% provides an indication of the cost of debt at that time.

HCA Healthcare, Inc. 8-K Report (Feb 12, 2003)

Summary

Key Highlights

Frequently Asked Questions